Mitsuhiro Ohta Selected Research

10-hydroxydecanoic acid

5/2022

Royal jelly fatty acids downregulate ANGPTL8 expression through the decrease in HNF4α protein in human hepatoma HepG2 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mitsuhiro Ohta Research Topics

Disease

11	Type 2 Diabetes Mellitus (MODY) 01/2010 - 12/2002
9	Insulin Resistance 01/2011 - 01/2004
8	Endometriosis 12/2007 - 01/2002
6	Parkinson Disease (Parkinson's Disease) 09/2006 - 07/2002
5	Obesity 04/2024 - 01/2004
5	Genetic Predisposition to Disease (Genetic Predisposition) 12/2007 - 01/2002
4	Myasthenia Gravis 06/2008 - 05/2003
3	Rheumatoid Arthritis 09/2014 - 03/2007
3	Infections 01/2013 - 10/2002
3	Neuroblastoma 09/2006 - 01/2003
2	Hypertension (High Blood Pressure) 11/2023 - 12/2006
2	Thrombosis (Thrombus) 11/2023 - 01/2019
2	Immune System Diseases (Immune Disorders) 09/2014 - 12/2007
2	Fibrosis (Cirrhosis) 03/2011 - 01/2011
2	Non-alcoholic Fatty Liver Disease 01/2011 - 04/2010
2	Hyperglycemia 01/2010 - 03/2009
2	Ischemia 10/2008 - 05/2005
2	Diabetic Retinopathy (Retinopathy, Diabetic) 09/2007 - 08/2003
2	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 11/2002 - 11/2002
1	Overweight 04/2024
1	Neoplasms (Cancer) 11/2023
1	Inflammation (Inflammations) 11/2023
1	Hepatocellular Carcinoma (Hepatoma) 05/2022
1	Body Weight (Weight, Body) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Tobacco Use Disorder (Nicotine Dependence) 01/2013
1	Chronic Hepatitis C 01/2013
1	Breast Neoplasms (Breast Cancer) 11/2012
1	Chronic Hepatitis (Chronic Active Hepatitis) 01/2011
1	Fatty Liver 01/2011
1	Stomach Neoplasms (Stomach Cancer) 12/2009
1	Hypoxia (Hypoxemia) 10/2008
1	Glucose Intolerance 03/2008
1	Atopic Dermatitis (Atopic Eczema) 02/2007

Drug/Important Bio-Agent (IBA)

5	CytokinesIBA 09/2014 - 08/2004
4	Proteins (Proteins, Gene)FDA Link 05/2022 - 01/2005
4	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 03/2008
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 05/2004
4	Interleukin-6 (Interleukin 6)IBA 03/2011 - 08/2003
4	Biomarkers (Surrogate Marker)IBA 07/2008 - 11/2002
3	Insulin (Novolin)FDA Link 01/2019 - 07/2005
3	Lipoproteins (Lipoprotein)IBA 01/2011 - 04/2008
3	Cholinergic ReceptorsIBA 12/2007 - 05/2003
3	ImmunosorbentsIBA 01/2004 - 11/2002
3	EnzymesIBA 01/2004 - 11/2002
2	Fatty Acids (Saturated Fatty Acids)IBA 05/2022 - 01/2011
2	Ribavirin (Virazole)FDA LinkGeneric 01/2013 - 01/2011
2	InterferonsIBA 01/2013 - 01/2011
2	oxidized low density lipoproteinIBA 01/2011 - 01/2010
2	LipidsIBA 01/2011 - 03/2008
2	nasIBA 01/2011 - 04/2010
2	LDL Lipoproteins (beta Lipoproteins)IBA 04/2010 - 04/2008
2	AdiponectinIBA 01/2010 - 12/2006
2	HLA Antigens (Human Leukocyte Antigens)IBA 12/2009 - 02/2003
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 07/2008 - 02/2007
2	muskIBA 06/2008 - 09/2007
2	AutoantibodiesIBA 06/2008 - 09/2007
2	Retinaldehyde (Retinal)IBA 09/2007 - 08/2003
2	pentosidineIBA 09/2007 - 08/2003
2	Advanced Glycation End ProductsIBA 09/2007 - 08/2003
2	Oxidopamine (6 Hydroxydopamine)IBA 09/2006 - 11/2003
2	Apomorphine FDA Link 09/2006 - 01/2003
2	Dopamine (Intropin)FDA LinkGeneric 09/2006 - 11/2003
2	ResistinIBA 01/2006 - 01/2004
2	AntibodiesIBA 07/2005 - 01/2004
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 05/2004 - 02/2003
2	Myelin Basic ProteinIBA 11/2002 - 11/2002
1	xanthoangelolIBA 04/2024
1	Chalcone (Benzalacetophenone)IBA 04/2024
1	ChalconesIBA 11/2023
1	sebacic acidIBA 05/2022
1	10-hydroxydecanoic acidIBA 05/2022
1	10-hydroxy-2-decenoic acidIBA 05/2022
1	royal jellyIBA 05/2022
1	Plasminogen Activator Inhibitor 1IBA 01/2019
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2019
1	Matrix Metalloproteinases (MMPs)IBA 09/2014
1	CholesterolIBA 01/2011
1	N 30IBA 01/2011
1	LDL CholesterolIBA 01/2011
1	Triglycerides (Triacylglycerol)IBA 01/2011
1	Ezetimibe (Zetia)FDA Link 01/2011
1	Collagen Type IV (Type IV Collagen)IBA 04/2010
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2010
1	Metformin (Glucophage)FDA LinkGeneric 01/2010
1	Pioglitazone (Actos)FDA Link 01/2010
1	Telmisartan (Micardis)FDA Link 03/2009
1	Superoxides (Superoxide)IBA 10/2008
1	10,10'-dimethyl-9,9'-biacridinium (Lucigenin)IBA 10/2008
1	Glycoside Hydrolase InhibitorsIBA 04/2008
1	glimepiride (Amarel)FDA LinkGeneric 04/2008
1	Acarbose FDA LinkGeneric 04/2008
1	HydrogenIBA 03/2008
1	Alkaline PhosphataseIBA 12/2007
1	KIR ReceptorsIBA 12/2007
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2007
1	Angiotensin Receptor AntagonistsIBA 09/2007
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2007

Therapy/Procedure

5	Therapeutics 01/2013 - 09/2006
1	Aftercare (After-Treatment) 01/2011